Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 | +$2.75B | |
| 2 | +$2.14B | |
| 3 | +$1.64B | |
| 4 |
Amazon
AMZN
|
+$1.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$983M |
Top Sells
| 1 | +$187M | |
| 2 | +$152M | |
| 3 | +$141M | |
| 4 |
Merck
MRK
|
+$137M |
| 5 |
TransDigm Group
TDG
|
+$133M |
Sector Composition
| 1 | Technology | 29.39% |
| 2 | Financials | 14.52% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAZE
2976
Maze Therapeutics
MAZE
$1.27B
| $2.34M | ﹤0.01% |
+212,464
|
|
||
|
FBLA
2977
FB Bancorp
FBLA
$216M
| $2.34M | ﹤0.01% |
207,462
+3,169
|
|
||
2978
GDS Holdings
GDS
$6.57B
| $2.34M | ﹤0.01% |
92,188
-4,745
|
|
||
2979
Xenon Pharmaceuticals
XENE
$3.29B
| $2.33M | ﹤0.01% |
69,597
+68
|
|
||
2980
Sera Prognostics
SERA
$128M
| $2.33M | ﹤0.01% |
634,252
+34,550
|
|
||
2981
Contango ORE
CTGO
$373M
| $2.33M | ﹤0.01% |
228,252
+6,178
|
|
||
2982
C&F Financial
CFFI
$221M
| $2.33M | ﹤0.01% |
34,523
+1,252
|
|
||
2983
Townsquare Media
TSQ
$104M
| $2.31M | ﹤0.01% |
283,472
+2,575
|
|
||
2984
MoonLake Immunotherapeutics
MLTX
$580M
| $2.3M | ﹤0.01% |
58,994
+44
|
|
||
2985
Abeona Therapeutics
ABEO
$280M
| $2.3M | ﹤0.01% |
482,619
+18,892
|
|
||
2986
Virco
VIRC
$117M
| $2.3M | ﹤0.01% |
242,831
+2,960
|
|
||
2987
Camtek
CAMT
$5.6B
| $2.29M | ﹤0.01% |
39,141
+24
|
|
||
2988
C4 Therapeutics
CCCC
$221M
| $2.29M | ﹤0.01% |
1,430,288
+49,202
|
|
||
|
RGLS
2989
DELISTED
Regulus Therapeutics
RGLS
| $2.28M | ﹤0.01% |
1,300,818
+21,487
|
|
||
|
EVBN
2990
DELISTED
Evans Bancorp Inc
EVBN
| $2.27M | ﹤0.01% |
58,201
+2,285
|
|
||
2991
Blink Charging
BLNK
$216M
| $2.26M | ﹤0.01% |
2,467,020
+177,913
|
|
||
2992
Taylor Devices
TAYD
$135M
| $2.26M | ﹤0.01% |
70,139
+2,714
|
|
||
2993
Eledon Pharmaceuticals
ELDN
$197M
| $2.26M | ﹤0.01% |
666,717
+3,616
|
|
||
2994
Hagerty
HGTY
$1.11B
| $2.26M | ﹤0.01% |
249,557
+8,630
|
|
||
2995
Editas Medicine
EDIT
$375M
| $2.26M | ﹤0.01% |
1,943,777
+135,214
|
|
||
|
IAUX
2996
i-80 Gold Corp
IAUX
$889M
| $2.25M | ﹤0.01% |
3,862,751
-24,096
|
|
||
2997
Everspin Technologies
MRAM
$238M
| $2.25M | ﹤0.01% |
440,332
+11,852
|
|
||
|
MRX
2998
Marex Group
MRX
$2.23B
| $2.25M | ﹤0.01% |
63,591
-4,317
|
|
||
|
PWOD
2999
DELISTED
Penns Woods Bancorp
PWOD
| $2.23M | ﹤0.01% |
80,050
+2,187
|
|
||
3000
Kodiak Sciences
KOD
$891M
| $2.23M | ﹤0.01% |
793,593
+24,899
|
|